Browsing: FDA

The FDA has approved Sunharbo (asundexian), Bayer’s once-daily pill to lower the risk of another stroke in adults who recently had a mild-to-moderate ischemic stroke or a high-risk mini-stroke. It is the first approved factor XIa inhibitor, a new type of blood thinner designed to stop harmful clots while limiting bleeding. The approval rests on the OCEANIC-STROKE trial of 12,327 patients, which found fewer repeat strokes without a significant rise in major bleeding. Sunharbo is taken alongside standard antiplatelet medicines. Doctors welcomed the option but say cost and insurance access could slow early use.